Clark David Michael sold FOLD
April 27, 2026 · Form 4 insider transaction
Clark David Michael sold 221,811 shares of Amicus Therapeutics, Inc. at $14.50 per share, a transaction worth $3.22M. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
221,811
Price
$14.50
Total value
$3.22M
InsiderClark David Michael
RoleOfficer
SecurityCommon Stock
Transaction codeD: Disposition to the issuer
Transaction dateApril 27, 2026
Filing dateApril 27, 2026
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported securities were disposed of in connection with consummation of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. (the "Merger"), which included 130,942 shares of Common Stock and 90,869 restricted stock units (which vested in full in connection with consummation of the Merger).